Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 4
- −1 vs. Q1 2023
- Portfolio value
- $60.2M
- −$114.7M (−65.6%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $39.6M | 65.8% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $15.6M | 25.8% | 00.0% | Unchanged | History |
| CELLBruker Cellular Analysis, Inc. | COM | 5,390,820 | $2.64M | 4.4% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $2.44M | 4.0% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (1)
Positions held at the end of Q1 2023 that are gone from this filing.